Cardiac impact of dapagliflozin in advanced chronic kidney disease: rationale and design of the Renal Lifecycle Trial cardiac imaging sub-studies

The Renal Lifecycle Trial and its sub-studies are registered at ClinicalTrials.gov under registration number NCT05374291.

Authors

Institutions

Publication Details

Journal
Clinical Kidney Journal
Published
2025-12-01
DOI
https://doi.org/10.1093/ckj/sfaf376
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cardiac impact of dapagliflozin in advanced chronic kidney disease: rationale and design of the Renal Lifecycle Trial cardiac imaging sub-studies

Ron T. Gansevoort, Laurent Billot, Brendon Lange Neuen, Loek van Heerebeek et al.
Clinical Kidney Journal
Diabetes Treatment and Management
article

Cardiac impact of dapagliflozin in advanced chronic kidney disease: rationale and design of the Renal Lifecycle Trial cardiac imaging sub-studies

Ron T. Gansevoort, Laurent Billot, Brendon Lange Neuen, Loek van Heerebeek, Helen Monaghan, Vlado Perkovic, Hiddo J.L. Heerspink, Rebecca Kozor, Christian Hamilton‐Craig, Marc Vervloet, Clare Arnott, Marc H. Hemmelder, Stefan P. Berger, James Otton, Angela Yee‐Moon Wang, Alferso C Abrahams, Lauren Houston, Dirk Kuypers, Lily Jakulj, M. Gelens, Bruce Charles Neal, Sunil V. Badve, Rianne H. A. C. M. de Bruin Bon, Adil Rajwani, Micky Karsten, Dean Guinness
article en

Abstract

The Renal Lifecycle Trial and its sub-studies are registered at ClinicalTrials.gov under registration number NCT05374291.

Clinical Kidney JournalVol. 19(1)
The University of Sydney (AU), University Medical Center Groningen (NL), Radboud University Nijmegen (NL), University of Groningen (NL), The George Institute for Global Health (GB), Singapore General Hospital (SG), Royal Perth Hospital (AU), Royal North Shore Hospital (AU), Maastricht University Medical Centre (NL), Erasmus MC (NL), Radboud University Medical Center (NL), University Medical Center Utrecht (NL), UNSW Sydney (AU), Maastricht University (NL), OLVG (NL), Dianet (NL), Amsterdam Neuroscience (NL), The George Institute for Global Health (AU), National Imaging Facility (AU), St George Hospital (AU), Kidney Health Australia (AU), ARC Centre of Excellence in Advanced Molecular Imaging (AU), Amsterdam University Medical Centers (NL), St. George Hospital (IN), University of Amsterdam (NL), KU Leuven (BE)
Amgen, Eli Lilly and Company, AstraZeneca, Bayer, GlaxoSmithKline, Sanofi, Biogen, Alexion Pharmaceuticals, CSL Behring, Fresenius Medical Care North America, Incyte, Argenx, Nierstichting, Novo Nordisk, Astellas Pharma, Universitair Medisch Centrum Groningen, Idorsia Pharmaceuticals, Illawarra Shoalhaven Local Health District, Seqirus, Medical Research Council, National Health and Medical Research Council, National Medical Research Council
Openalex Percentile: Top 50%
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.